TRYAL - About the company
TRYAL is an unfunded company based in Austin (United States), founded in 2022. It operates as a Provider of AI enabled clinical trial software. TRYAL has not raised any funding yet. The company has 244 active competitors, including 38 funded and 11 that have exited. Its top competitors include companies like TigerConnect, Ferrum Health and RISA Labs.
Company Details
Provider of AI enabled clinical trial software. It offers a platform that supports eCOA, eConsent, eSource, EDC, and Televisit. It offers a range of features designed to streamline the clinical trial process and home health care module to manage remote visits in clinical studies for managing remote data collection and participant interactions.
Key Metrics
Founded Year
2022
Location
Austin, United States
Stage
Unfunded
Ranked
127th among 244 active competitors
Employee Count
18 as on Jan 31, 2026
Similar Companies
Sign up to download TRYAL's company profile
TRYAL's funding and investors
TRYAL has not raised any funding rounds yet.
TRYAL's founders and board of directors
Founder? Claim ProfileTRYAL's employee count trend
TRYAL has 18 employees as of Jan 26. Here is TRYAL's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
TRYAL's Competitors and alternates
Top competitors of TRYAL include TigerConnect, Ferrum Health and RISA Labs. Here is the list of Top 10 competitors of TRYAL, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | TigerConnect 2010, Santa Monica (United States), Series E | Provider of a cloud-based collaboration and communication platform for healthcare professionals | $426M | 67/100 | |
2nd | Ferrum Health 2017, Sunnyvale (United States), Series A | AI-based medical data analysis software for population health management | $31M | 62/100 | |
3rd | RISA Labs 2024, Cambridge (United States), Series A | Provider of solutions for automating clinical operation | $14.6M | 62/100 | |
4th | WellSheet 2015, New York City (United States), Series A | Provider of a web applications for care quality and productivity improvement | $9.94M | 61/100 | |
5th | Radformation 2014, New York City (United States), Series A | Intelligent automation software for cancer clinics, increasing plan quality and efficiency | $11.5M | 59/100 | |
6th | E5 AI 2019, San Jose (United States), Series B | Cloud-based platform for workflow automation | $48.5M | 59/100 | |
7th | Fabric 2021, New York City (United States), Series A | Provider of a care enablement system for healthcare and clinics | $80M | 56/100 | |
8th | UnityAI 2023, Nashville (United States), Series A | Developer of AI solutions for streamlining healthcare operations and workflows | $15M | 53/100 | |
9th | Mendel Health 2017, San Jose (United States), Series B | Provider of AI-powered clinical data platform solutions for the life sciences and healthcare industries | $60.2M | 51/100 | |
10th | Agamon 2018, New York City (United States), Seed | AI and cloud-based online platform offering clinical data analytics | $8M | 51/100 | |
127th | TRYAL 2022, Austin (United States), Unfunded | Provider of AI enabled clinical trial software | - | - | 21/100 |
Looking for more details on TRYAL's competitors? Click here to see the top ones
TRYAL's Investments and acquisitions
TRYAL has made no investments or acquisitions yet.
Reports related to TRYAL
Here is the latest report on TRYAL's sector:
Are you a Founder ?
FAQs about TRYAL
Explore our recently published companies
- Parakeet.ai - 2021 founded, Unfunded company
- Kooshboo - Kuala Lumpur based, 2025 founded, Unfunded company
- Laurel Creek Lodge - Holmesville based, 2025 founded, Funding Raised company
- Careturn - Petaling Jaya based, 2017 founded, Unfunded company
- Ceo Kids - Hong Kong based, 1995 founded, Unfunded company
- Baylinkvoicemail - Unfunded company
